Publications by authors named "Daniela Rau"

Claim this Profile
F
First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditions.
Christoph Kleinschnitz, Jelena Skuljec, Markus C Kowarik, Michael Ernst, Lara Woitschach, Daniela Rau

Mult Scler Relat Disord· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 - Results from a German cladribine cohort.
Markus C Kowarik, Michael Ernst, Lara Woitschach, Lukas Cepek, Daniela Rau

Mult Scler Relat Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis.
Daniela Rau, Beate Müller, Susanne Übler

Adv Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the treating physicians' first-hand experience with handling and satisfaction of ofatumumab therapy: findings from the PERITIA survey conducted in Europe.
Daniela Rau, Sara Eichau, Giovanna Borriello, João Cerqueira, Carola Wagner

BMC Neurol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice.
Martin Stangel, Veit Becker, Birte Elias-Hamp, Joachim Havla, Christoph Grothe, Daniela Rau

Mult Scler Relat Disord· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ID-Associated Application to Facilitate Patient-Tailored Management of Multiple Sclerosis.
Michael Lang, Daniela Rau, Lukas Cepek, Fia Cürten, Stefan Ringbauer

Brain Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental symptoms in MS (MeSyMS): Development and validation of a new assessment.
Melanie Filser, Sharon Jean Baetge, Carolin Balloff, Axel Buchner, Gereon Rudolf Fink, Daniela Rau

Mult Scler Relat Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis--Report of Two Cases.
Daniela Rau, Michael Lang, Andreas Harth, Markus Naumann, Frank Weber

Int J Mol Sci· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid.
Hayrettin Tumani, Martin Pfeifle, Vera Lehmensiek, Daniela Rau, Helga Mogel

J Neuroimmunol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis